883 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Purchased by Kingswood Wealth Advisors LLC

Kingswood Wealth Advisors LLC acquired a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 883 shares of the biotechnology company’s stock, valued at approximately $525,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Quent Capital LLC raised its stake in Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after purchasing an additional 75 shares during the last quarter. Prestige Wealth Management Group LLC raised its position in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 44 shares during the last quarter. Versant Capital Management Inc boosted its position in Axon Enterprise by 4,750.0% during the fourth quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company’s stock worth $58,000 after acquiring an additional 95 shares during the last quarter. Berbice Capital Management LLC purchased a new stake in Axon Enterprise during the 4th quarter valued at about $59,000. Finally, Brooklyn Investment Group acquired a new stake in Axon Enterprise in the 3rd quarter valued at about $41,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Activity

In related news, Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the sale, the director now owns 2,392 shares in the company, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the transaction, the director now directly owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. This represents a 3.96 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 50,545 shares of company stock worth $30,721,337. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Up 0.4 %

Shares of NASDAQ AXON opened at $639.97 on Thursday. The stock has a market capitalization of $48.80 billion, a price-to-earnings ratio of 165.37, a price-to-earnings-growth ratio of 6.09 and a beta of 1.04. Axon Enterprise, Inc. has a 52 week low of $247.04 and a 52 week high of $698.67. The firm has a 50-day moving average price of $618.90 and a 200 day moving average price of $477.78. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. Needham & Company LLC increased their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday. Northland Securities raised their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, JMP Securities lifted their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $524.85.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.